1
Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F.M., Brouwer, Rolf E., Issa, Djamila E., de Jong, Daphne, Lam, King H., Blijlevens, Nicole M.A., Zijlstra, Josée M., Chamuleau, Martine E.D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.
Veröffentlicht in: Durmaz , M , Visser , O , Posthuma , E F M , Brouwer , R E , Issa , D E , de Jong , D , Lam , K H , Blijlevens , N M A , Zijlstra , J M , Chamuleau , M E D , Lugtenburg , P J , Kersten , M J & Dinmohamed , A G 2022 , ' Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage : a nationwide, population-based study in the Netherlands, 1989–2018 ' , Blood Cancer Journal , vol. 12 , no. 3 , 38 . https://doi.org/10.1038/s41408-022-00637-1;
2022
Veröffentlicht in: Durmaz , M , Visser , O , Posthuma , E F M , Brouwer , R E , Issa , D E , de Jong , D , Lam , K H , Blijlevens , N M A , Zijlstra , J M , Chamuleau , M E D , Lugtenburg , P J , Kersten , M J & Dinmohamed , A G 2022 , ' Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage : a nationwide, population-based study in the Netherlands, 1989–2018 ' , Blood Cancer Journal , vol. 12 , no. 3 , 38 . https://doi.org/10.1038/s41408-022-00637-1;
2022
2
Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F. M., Brouwer, Rolf E., Issa, Djamila E., de Jong, Daphne, Lam, King H., Blijlevens, Nicole M. A., Zijlstra, Josée M., Chamuleau, Martine E. D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.
Veröffentlicht in: Blood Cancer Journal ; volume 12, issue 3 ; ISSN 2044-5385;
2022
Veröffentlicht in: Blood Cancer Journal ; volume 12, issue 3 ; ISSN 2044-5385;
2022
3
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S.P., Zijlstra, Josée M., Chamuleau, Martine E.D., Kersten, Marie José, Plattel, Wouter J., Durmaz, Mujde, Lugtenburg, Elly, Stevens, Wendy B.C., Mous, Rogier, de Vries, Elisabeth G.E., van der Poel, Marjolein W.M., Nannan Panday, Prashant V., Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M E D , Kersten , M J , Plattel , W J , Durmaz , M , Lugtenburg , E , Stevens , W B C , Mous , R , de Vries , E G E , van der Poel , M W M , Nannan Panday , P V , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood advances , vol. 5 , no. 15 , pp. 2985-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M E D , Kersten , M J , Plattel , W J , Durmaz , M , Lugtenburg , E , Stevens , W B C , Mous , R , de Vries , E G E , van der Poel , M W M , Nannan Panday , P V , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood advances , vol. 5 , no. 15 , pp. 2985-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021